Aprameya Engineering Ltd

Aprameya Enginee Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aprameya Engineering Ltd

₹ 149 -2.61%
24 Jul 3:47 p.m.
aelhealth.com NSE - SME: APRAMEYA
About

Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]

Key Points

Business Segments
A) Healthcare Infrastructure Projects[1][2]
The company offers turnkey solutions for developing healthcare facilities, covering everything from design to execution of ICUs, NICUs, PICUs, Modular Operation Theatres (MOTs), Dialysis Centers, and Prefabricated Wards. The scope also includes integration of MEP systems, fire safety, structural design, and hospital interiors. These projects are tailored for public healthcare institutions, focused on customized infrastructure delivery.

Website NSE - SM
  • Market Cap ₹ 284 Cr.
  • Current Price ₹ 149
  • High / Low ₹ 360 / 140
  • Stock P/E 56.3
  • Book Value ₹ 36.4
  • Dividend Yield 0.00 %
  • ROCE 12.6 %
  • ROE 7.54 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has high debtors of 368 days.
  • Company's cost of borrowing seems high
  • Working capital days have increased from 232 days to 377 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2024 Mar 2025 Sep 2025 Mar 2026
9.27 126.43 42.14 12.61
10.65 100.65 31.12 13.21
Operating Profit -1.38 25.78 11.02 -0.60
OPM % -14.89% 20.39% 26.15% -4.76%
0.28 0.31 0.19 0.29
Interest 1.15 2.03 2.03 1.61
Depreciation 0.05 0.05 0.05 0.05
Profit before tax -2.30 24.01 9.13 -1.97
Tax % -24.78% 25.70% 25.96% -12.18%
-1.73 17.84 6.76 -1.72
EPS in Rs -0.91 9.37 3.55 -0.90
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
12.23 25.93 35.00 78.12 65.16 135.71 54.75
10.64 23.52 24.95 68.67 58.81 111.31 44.34
Operating Profit 1.59 2.41 10.05 9.45 6.35 24.40 10.41
OPM % 13.00% 9.29% 28.71% 12.10% 9.75% 17.98% 19.01%
0.09 0.08 0.04 0.21 0.46 0.59 0.49
Interest 0.90 0.87 0.14 2.08 2.11 3.18 3.64
Depreciation 0.07 0.09 0.02 0.08 0.09 0.09 0.09
Profit before tax 0.71 1.53 9.93 7.50 4.61 21.72 7.17
Tax % 8.45% 43.79% 24.87% 27.33% 24.30% 25.78% 29.71%
0.65 0.86 7.46 5.45 3.49 16.12 5.04
EPS in Rs 10.66 3.89 2.49 8.47 2.65
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 16%
3 Years: -11%
TTM: -60%
Compounded Profit Growth
10 Years: %
5 Years: 42%
3 Years: -3%
TTM: -69%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -10%
Return on Equity
10 Years: %
5 Years: 24%
3 Years: 19%
Last Year: 8%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3.74 4.34 7.00 14.00 14.00 19.04 19.04
Reserves 0.00 0.00 7.45 5.93 9.40 45.22 50.30
4.03 1.48 13.69 28.74 42.05 30.34 7.12
6.21 5.09 20.49 13.21 10.19 49.36 5.40
Total Liabilities 13.98 10.91 48.63 61.88 75.64 143.96 81.86
0.69 0.63 1.54 1.49 1.43 1.38 1.39
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.35
13.29 10.28 47.09 60.39 74.21 142.58 80.12
Total Assets 13.98 10.91 48.63 61.88 75.64 143.96 81.86

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.06 3.58 10.41 -13.49 -9.97 -10.64 31.48
-0.57 0.03 -0.24 -1.83 -1.00 -0.41 -4.01
0.54 -3.67 -7.69 13.04 11.11 10.89 -27.65
Net Cash Flow 0.04 -0.06 2.48 -2.28 0.14 -0.16 -0.18
Free Cash Flow -0.31 3.55 10.38 -13.52 -10.58 -10.89 31.31
CFO/OP 22% 173% 149% -115% -133% -28% 333%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 182.35 57.99 278.23 195.30 325.23 320.38 367.87
Inventory Days 245.38 121.90 454.87 375.97 73.78 81.04
Days Payable 268.89 146.76 1,099.89 414.62 145.83 95.38
Cash Conversion Cycle 158.84 33.13 -366.78 156.66 253.19 320.38 353.53
Working Capital Days 39.69 36.32 199.92 116.43 152.76 165.60 377.40
ROCE % 35.32% 59.31% 24.94% 11.78% 31.12% 12.64%

Insights

In beta
Mar 2024 Mar 2025
Customer Concentration from Top Customer
% of total revenue

Log in to view insights

Please log in to see hidden values.

Login
Revenue Mix - Turnkey Project Supply
% of total revenue
Critical Care Beds Installed (Cumulative)
count
Dialysis Centers Delivered (Cumulative)
count
Number of OEM Partnerships (Authorized Distributors)
count
Number of States of Operation
count
Order Book
Rs Mn

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2024Mar 2025Sep 2025Mar 2026
73.53% 73.53% 73.53% 74.05%
2.47% 0.41% 0.00% 0.00%
5.38% 0.72% 0.77% 0.70%
18.62% 25.34% 25.70% 25.24%
No. of Shareholders 749628822933

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls